Home / Companies / Torrent Pharmaceuticals Limited / 28 Apr 2026
Torrent Pharmaceuticals Limited: meeting of 28 Apr 2026
Votes reported on Form N-PX, item by item
65 Form N-PX filers reported votes at the Torrent Pharmaceuticals Limited meeting of 28 Apr 2026. Their records fall into 2 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
EXTRAORDINARY TRANSACTIONSIssuer
EXTRAORDINARY TRANSACTIONS: management items
Management items in this category are shown together; filers word and number them differently.
111 vote records from 60 filers. 0 of the 59 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
6 vote records from 6 filers. 0 of the 6 filers that marked the item either way voted against management.
How the largest families voted
None of the families tracked on this site reported a position on these items.
Questions
How did large funds vote at the Torrent Pharmaceuticals Limited meeting?
65 Form N-PX filers reported votes at the meeting of 28 Apr 2026. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Torrent Pharmaceuticals Limited on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Torrent Pharmaceuticals Limited
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Torrent Pharmaceuticals Limited with a meeting date within three days of 28 Apr 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.